Kodiak Sciences (KOD) Earnings Analysis
Kodiak Sciences (KOD) next reports earnings on 2026-08-12, consensus EPS -0.97 USD. Last quarter (2026-03-31) it missed with EPS -1.04 USD vs -1.02 USD est (-2%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E -10.05.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does KOD next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | -0.97 USD |
| Revenue estimate | n/a |
KOD earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-31 | -1.04 USD | -1.02 USD | -2% | Miss |
| 2025-11-13 | -1.16 USD | -1.07 USD | -8.4% | Miss |
| 2025-08-13 | -1.03 USD | -1.01 USD | -2% | Miss |
| 2025-05-14 | -1.09 USD | -0.89 USD | -22.5% | Miss |
| 2024-11-14 | -0.84 USD | -0.9 USD | +6.7% | Beat |
| 2024-08-14 | -0.86 USD | -0.87 USD | +1.1% | Beat |
Beat rate: 2/6 (33%) over reported quarters with consensus data.
KOD valuation and analyst view
| Trailing P/E | -10.05 |
|---|---|
| Trailing EPS | -3.72884 USD |
| Price / book | 23.13 |
| Dividend yield | 0.00% |
| Market cap | 2.22B |
| Analyst consensus | Buy (13 buy / 4 hold / 1 sell) |
| Avg price target | 61 USD |
Related research pages
Frequently asked questions
When is Kodiak Sciences (KOD)'s next earnings date?
Kodiak Sciences is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.97 USD.
Did KOD beat earnings last quarter?
In its 2026-03-31 report, KOD posted EPS of -1.04 USD versus a -1.02 USD estimate — a miss of 2%.
What is KOD's earnings track record?
Over the last 6 reported quarters with consensus data, KOD beat estimates 2 times (33%).
What is KOD's current P/E ratio and EPS?
KOD trades at a trailing P/E of -10.05 on trailing EPS of -3.7288380270220483 USD.
What do analysts rate KOD?
Analyst consensus is "Buy" across 18 ratings (0 strong buy, 13 buy, 4 hold, 1 sell, 0 strong sell). Average 12-month price target: 61 USD.